Delivery Order SPE2DB20D1109-SPE2DB25FP48Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Progesterone 200 mg capsules (100-count units) with a ceiling value of $32,993.69. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a non-set-aside award made through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency awarded a delivery order valued at $14,740.75 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $9,242.11 to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for Progesterone 200 mg capsules (100 count) with a ceiling value of $23,942.71. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. The contract is expected to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count units) with a ceiling value of $4,362.15. This competitively awarded, non-set-aside contract was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and is structured as a firm fixed price delivery order. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100-count units) under a firm fixed-price contract valued at $32,928.71. The award, effective August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract valued at $6,082.96, with an ultimate completion date of July 31, 2025. This non-set-aside delivery order was competitively awarded and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare supplier,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Progesterone 100 mg capsules in quantities of 30 units. This competitively awarded, non-set-aside delivery order carries a ceiling value of $7,001.13 and is scheduled for completion by July 30, 2025. The contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with the federal...
- The Defense Logistics Agency awarded a $3,125.26 delivery order to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) under a firm fixed-price contract type. The order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct procurement with no set-aside designation. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,578.30 to AmerisourceBergen Drug Corp for the supply of Progesterone 200 mg capsules (100 count) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP48YDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Progesterone 200 mg capsules (100-count) with a ceiling value of $3,968.44. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is classified as a delivery order, with an ultimate completion date of July 31, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major pharmaceutical distributor specializing in federal medical procurement for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse pharmaceutical needs across multiple therapeutic domains through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 7/30/25 |